Circulating Tumor DNA Correlates With Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors – Results of a Prospective Biomarker Study

Andrea Forschner1, Stephanie Weißgraeber2, Dirk Hadaschik2, Martin Schulze3, Maria Kopp2, Sabine Kelkenberg2, Tobias Sinnberg1, Claus Garbe1, Saskia Biskup2,3, Florian Battke2.
  1. Center for Dermatooncology, Department of Dermatology, University Hospital Tuebingen, Tuebingen, Germany.
  2. Center for Genomics and Transcriptomics (CeGaT) GmbH, Tuebingen, Germany.
  3. Practice for Human Genetics, Tuebingen, Germany.